PubHive Announces Real-Time Access to Clinical Trial Data
LONDON, November 27, 2023 – PubHive Ltd., a leading provider of scientific literature & safety information workflows provider, today announced the seamless integration of clinical trial data sources, providing clinical researchers and healthcare professionals with unparalleled real-time access to critical information and enabling them to conduct research more efficiently and effectively.
Clinical trial data providers play a pivotal role in disseminating information about ongoing clinical research studies, serving as a vital resource for professionals engaged in medical research. By integrating with these sources, PubHive amplifies the utility of clinical trial data, offering a dynamic platform for researchers, medical writers, and clinical and scientific officers.
This unprecedented integration grants users a comprehensive database of clinical trials, encompassing details about the compound under investigation, the study's synopsis, and the study design. Additionally, users can leverage PubHive's real-time search capabilities to identify clinical trials that align with their specific criteria.
“PubHive's commitment to advancing research and streamlining clinical trial processes is at the core of our latest integration” stated Raj Vaghela, CEO at PubHive. “Real-time access to comprehensive clinical trial data sources empowers researchers and medical writers to make informed decisions, enhance strategy, and expedite document preparation.”
Clinical and Scientific Officers can leverage PubHive's platform to inform their strategic decision-making, outsourcing initiatives, and regulatory documentation processes. Medical Writers can seamlessly incorporate real-time clinical trial data into their medical and clinical documents, ensuring the utmost accuracy and timeliness.
PubHive offers advanced filtering options based on study status, type, phase, results, and different important dates to further streamline the search process.
This empowers users to quickly locate trials relevant to their specific interests.
PubHive's commitment to providing the most up-to-date and accurate clinical trial information extends to its discovery feature. This feature informs users about trials accepting healthy volunteers, along with other pertinent clinical trial parameters.
In essence, this integration represents a significant stride towards simplifying the complex landscape of clinical research, providing a user-friendly and powerful platform for professionals at every stage of the process.
To explore more about PubHive and the PubHive Navigator platform, visit the PubHive website at https://pubhive.com.
About PubHive
PubHive Ltd. is a cloud-based software company with a mission to make healthier scientific literature and safety workflows for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator, the company’s scientific workflow management platform, optimizes existing business processes and automates repetitive work for teams in regulatory and medical affairs, research and development, clinical affairs, drug safety, pharmacovigilance, medical devices, CER/PMCF, medical communication/writing, library, information management, document delivery, literature monitoring & reporting and other divisions. Powered by a proprietary Omni-Loop Artificial Intelligence (AI)™ engine, PubHive Navigator is the only 'fit for purpose' one-stop enterprise scientific workflow automation platform today, distinguishing itself through flexible end-to-end workstreams and intuitive interfaces that make literature handling quick and easy.